Sunil Badve's Publications

About Sunil Badve's Publications

Program Lead, Cardiometabolic Trials, Renal and Metabolic Program

  • Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease

    Annals of Internal Medicine Date published:

  • SUN-292 BENEFITS AND HARMS OF VITAMIN D COMPOUNDS IN ADULTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS

    Kidney International Reports Date published:

  • SAT-224 ESTIMATES OF DIETARY PHOSPHATE CONSUMPTION AND COMMON FOOD SOURCES OF PHOSPHATE IN AUSTRALIANS WITH CHRONIC KIDNEY DISEASE

    Kidney International Reports Date published:

  • 1216-P: The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program

    Diabetes Date published:

  • Dual Inhibition of Gastrointestinal Phosphate Absorption: More Questions Than Answers

    Journal of the American Society of Nephrology Date published:

  • Recent evidence for direct oral anticoagulants in chronic kidney disease

    Current Opinion in Nephrology and Hypertension Date published:

  • Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial

    PLoS ONE Date published:

  • The Association of Functional Status with Mortality and Dialysis Modality Change: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)

    Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis Date published:

  • Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study

    BMJ Open Date published:

  • The effects of canagliflozin on uric acid and gout in patients with type 2 diabetes in the CANVAS programme

    Date published:

  • Benefits and harms of oral anticoagulant therapy in chronic kidney disease: a systematic review and meta-analysis

    Annals of Internal Medicine Date published:

  • Differences in peritoneal dialysis technique survival between patients treated with peritoneal dialysis systems from different companies

    Nephrology Dialysis Transplantation Date published:

  • Urate-Lowering Therapy for Preventing Kidney Disease Progression: Are We There Yet?

    American Journal of Kidney Diseases Date published:

  • Biocompatible dialysis fluids for peritoneal dialysis

    Cochrane Database of Systematic Reviews Date published:

  • Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease

    Cochrane Database of Systematic Reviews Date published:

  • Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study

    American Journal of Kidney Diseases Date published: